303 related articles for article (PubMed ID: 20824733)
1. Levodopa and subthalamic deep brain stimulation responses are not congruent.
Zaidel A; Bergman H; Ritov Y; Israel Z
Mov Disord; 2010 Oct; 25(14):2379-86. PubMed ID: 20824733
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
3. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
4. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
6. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
9. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
10. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
11. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
12. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
14. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
[TBL] [Abstract][Full Text] [Related]
16. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
[TBL] [Abstract][Full Text] [Related]
17. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
18. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
Gierthmühlen J; Arning P; Binder A; Herzog J; Deuschl G; Wasner G; Baron R
Mov Disord; 2010 Jul; 25(9):1195-202. PubMed ID: 20629160
[TBL] [Abstract][Full Text] [Related]
19. Deep brain stimulation effects on gait variability in Parkinson's disease.
Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
